健康元
(600380)
| 流通市值：211.85亿 | | | 总市值：211.85亿 |
| 流通股本：18.29亿 | | | 总股本：18.29亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 11,898,828,905.02 | 8,234,634,099.45 | 4,339,814,452.16 | 16,646,350,349.72 |
| 营业收入 | 11,898,828,905.02 | 8,234,634,099.45 | 4,339,814,452.16 | 16,646,350,349.72 |
| 二、营业总成本 | 9,121,682,123.61 | 6,247,787,990.98 | 3,296,136,273.86 | 13,123,515,536.16 |
| 营业成本 | 4,393,919,087.41 | 3,021,125,884.33 | 1,588,615,523.54 | 6,298,465,671.11 |
| 税金及附加 | 137,567,242.03 | 93,999,188.76 | 46,715,949.27 | 203,209,120.85 |
| 销售费用 | 2,951,059,287.9 | 2,096,637,821.45 | 1,097,660,861.66 | 4,434,442,281.05 |
| 管理费用 | 708,729,617.84 | 445,024,332.82 | 259,688,090.97 | 930,481,615.7 |
| 研发费用 | 1,036,376,310.06 | 714,729,729.75 | 377,100,491.98 | 1,661,757,980.9 |
| 财务费用 | -105,969,421.63 | -123,728,966.13 | -73,644,643.56 | -404,841,133.45 |
| 其中:利息费用 | 94,972,898.62 | 72,457,072.68 | 33,732,578.57 | 146,728,005.05 |
| 其中:利息收入 | 245,985,558.7 | 187,438,919.12 | 102,748,969.84 | 532,253,758.86 |
| 加:公允价值变动收益 | -5,736,443.62 | -19,576,467.55 | 1,161,062.53 | -25,419,715.12 |
| 加:投资收益 | 51,650,239.89 | 35,345,305.87 | 20,421,061.35 | 79,474,572.01 |
| 资产处置收益 | -370,399.04 | -76,440.36 | 306,572.18 | -169,901.01 |
| 资产减值损失(新) | -113,694,072.7 | -82,185,254.98 | -4,077,243.26 | -312,369,926.37 |
| 信用减值损失(新) | -797,210.83 | -3,873,446.7 | -6,583,395.98 | -16,846,468.56 |
| 其他收益 | 124,184,202.58 | 70,438,830.56 | 35,611,817.69 | 259,061,799 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 2,832,383,097.69 | 1,986,918,635.31 | 1,090,518,052.81 | 3,506,565,173.51 |
| 加:营业外收入 | 6,920,279.4 | 4,941,102.08 | 1,879,698.62 | 7,980,415.72 |
| 减:营业外支出 | 19,988,508.91 | 9,830,386.52 | 5,878,094.77 | 48,990,788.1 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 2,819,314,868.18 | 1,982,029,350.87 | 1,086,519,656.66 | 3,465,554,801.13 |
| 减:所得税费用 | 385,618,343.11 | 285,813,843.86 | 161,422,518.85 | 614,535,757.76 |
| 六、净利润 | 2,433,696,525.07 | 1,696,215,507.01 | 925,097,137.81 | 2,851,019,043.37 |
| 持续经营净利润 | 2,433,696,525.07 | 1,696,215,507.01 | 925,097,137.81 | 2,851,019,043.37 |
| 归属于母公司股东的净利润 | 1,111,560,063.92 | 776,424,466.87 | 439,798,106.55 | 1,442,779,722.23 |
| 少数股东损益 | 1,322,136,461.15 | 919,791,040.14 | 485,299,031.26 | 1,408,239,321.14 |
| (一)基本每股收益 | 0.59 | 0.42 | 0.24 | 0.76 |
| (二)稀释每股收益 | 0.59 | 0.42 | 0.24 | 0.76 |
| 八、其他综合收益 | -86,688,069.37 | -29,097,306.9 | -22,546,561.73 | -35,859,587.07 |
| 归属于母公司股东的其他综合收益 | -59,369,859.17 | -23,675,110.79 | -10,032,811.3 | -14,877,862.38 |
| 九、综合收益总额 | 2,347,008,455.7 | 1,667,118,200.11 | 902,550,576.08 | 2,815,159,456.3 |
| 归属于母公司股东的综合收益总额 | 1,052,190,204.75 | 752,749,356.08 | 429,765,295.25 | 1,427,901,859.85 |
| 归属于少数股东的综合收益总额 | 1,294,818,250.95 | 914,368,844.03 | 472,785,280.83 | 1,387,257,596.45 |
| 公告日期 | 2024-10-25 | 2024-08-24 | 2024-04-26 | 2024-04-03 |
| 审计意见(境内) | | | | 标准无保留意见 |